Results 81 to 90 of about 43,184 (256)
Immunoapheresis in Paraneoplastic Pemphigus [PDF]
Archives of Dermatology, 1998 Paraneoplastic pemphigus was first described in 1990 in 5 patients with extensive mucocutaneous erosions, a distinct set of autoantibodies, and underlying neoplasia. Since then, patients described have been middle-aged, have suffered from prognostically unfavorable malignant neoplasms, and have responded poorly to immunosuppressive agents.A 16-year-old
H, Schoen +6 more
openaire +2 more sources
Ain Shams Journal of Anesthesiology, 2019 Background Castleman’s disease is a rare lymphoproliferative disease which can mimic other malignant tumours and can be associated with paraneoplastic pemphigus especially in the paediatric age group.
Rajasree O. +3 more
doaj +1 more source
Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies [PDF]
, 2014 During recent years, an increasing number of neuromuscular diseases have been recognized either to be caused primarily by autoimmune mechanisms, or to have important autoimmune components.
Oliveira, Acary Souza Bulle +2 more
core +3 more sources
ORAL PEMPHIGUS VULGARIS IN OLD WOMAN: CONDUCTS OF A CHALLENGING CASE
Revista Naval de Odontologia On Line, 2021 Pemphigus is an autoimmune disease that, depending on the level of epithelial involvement, can be classified into pemphigus vulgaris, vegetans, erythematosus and foliaceus.
João Cesar Guimarães Henriques +3 more
doaj +1 more source
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review [PDF]
, 2020 Haematological malignancies induce important alterations of the immune system, which account for the high frequency of autoimmune complications observed in patients. Cutaneous immune-mediated diseases associated with haematological malignancies encompass
A. Guglielmo +8 more
core +1 more source
Journal of Cutaneous Pathology, EarlyView.ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina +5 more
wiley +1 more source
The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. [PDF]
PLoS ONE, 2010 BackgroundParaneoplastic pemphigus (PNP) is a devastating autoimmune blistering disease, involving mucocutaneous and internal organs, and associated with underlying neoplasms. PNP is characterized by the production of autoantibodies targeting proteins of
Isabelle Schepens +7 more
doaj +1 more source
Paraneoplastic pemphigus. A trait d’union between dermatology and oncology [PDF]
, 2015 Paraneoplastic pemphigus is a rare autoimmune disease of the skin associated with neoplasm. Nowadays, the pathogenesis of paraneoplastic pemphigus is not fully understood. Due to its rarity, various criteria have been proposed for the diagnosis. For this
Calvieri, Stefano +6 more
core +2 more sources
Prognostic Factors of Paraneoplastic Pemphigus [PDF]
Archives of Dermatology, 2012 To identify the prognostic factors of overall survival in a series of patients with paraneoplastic pemphigus (PNP).Multicenter retrospective cohort study.Twenty-seven dermatology departments in France.A total of 53 patients (31 men and 22 women; median age, 59 years; age range, 30-88 years) were diagnosed as having PNP between 1992 and 2010.Overall ...
Leger, Sandy +34 more
openaire +4 more sources
Journal of Oral Pathology &Medicine, EarlyView.ABSTRACT Objectives Direct immunofluorescence (DIF) is the gold standard for diagnosing subepidermal blistering diseases (SBDs). However, DIF requires specialized expertise; therefore, alternative immunological methods such as enzyme‐linked immunosorbent assays (ELISA) are worth exploring. The aim of this review was to evaluate the diagnostic agreement
Romeo Patini +9 more
wiley +1 more source